<p>The present invention is directed to a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.</p>
申请公布号
EP2427190(B1)
申请公布日期
2013.09.18
申请号
EP20100719818
申请日期
2010.05.07
申请人
TETRAPHASE PHARMACEUTICALS, INC.
发明人
CLARK, ROGER, B.;HE, MINSHENG;PLAMONDON, LOUIS;XIAO, XIAO-YI;RONN, MAGNUS
